PHL Médecine: what changed
You see two financial years side by side: what moved most in the balance sheet and the result, why the result rose or fell and where the money went.
PHL Médecine
Largest movements
- Cash +€60,170
up €60,170 (+164%), from €36,623 to €96,793
mainly Net result for the year (+€106,296) and Tax, wage and social debts (+€1,100)
- Receivables within one year +€30,042
up €30,042 (+22,496%), from €134 to €30,175
- Deferred charges and accrued income +€13,900
up €13,900 (+32.1%), from €43,293 to €57,193
- Profit (loss) carried forward +€106,296
up €106,296 (+198%), from €53,765 to €160,061
- Other debts -€4,249
down €4,249 (-85.2%), from €4,987 to €738
- Gross operating margin +€63,339
up €63,339 (+87.8%), from €72,167 to €135,506
- Taxes +€11,088
up €11,088 (+61.6%), from €18,000 to €29,088
Change in the result, 2023 to 2024
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €80,050 | €184,162 | +€104,112 | +130% |
| Current assets | 29/58 | €80,050 | €184,162 | +€104,112 | +130% |
| Amounts receivable within one year | 40/41 | €134 | €30,175 | +€30,042 | +22,496% |
| Other amounts receivable | 41 | €134 | €30,175 | +€30,042 | +22,496% |
| Cash at bank and in hand | 54/58 | €36,623 | €96,793 | +€60,170 | +164% |
| Deferred charges and accrued income | 490/1 | €43,293 | €57,193 | +€13,900 | +32.1% |
| Total equity and liabilities | 10/49 | €80,050 | €184,162 | +€104,112 | +130% |
| Equity | 10/15 | €56,765 | €163,061 | +€106,296 | +187% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €53,765 | €160,061 | +€106,296 | +198% |
| Amounts payable | 17/49 | €23,285 | €21,100 | -€2,184 | -9.4% |
| Amounts payable within one year | 42/48 | €23,194 | €21,100 | -€2,093 | -9.0% |
| Trade debts | 44 | €207 | €1,262 | +€1,056 | +511% |
| Suppliers | 440/4 | €207 | €1,262 | +€1,056 | +511% |
| Taxes, remuneration and social security | 45 | €18,000 | €19,100 | +€1,100 | +6.1% |
| Taxes | 450/3 | €18,000 | €19,100 | +€1,100 | +6.1% |
| Other amounts payable | 47/48 | €4,987 | €738 | -€4,249 | -85.2% |
| Accrued charges and deferred income | 492/3 | €91 | - | -€91 | |
| Other operating charges | 640/8 | €384 | €387 | +€3 | +0.8% |
| Gross operating margin | 9900 | €72,167 | €135,506 | +€63,339 | +87.8% |
| Operating profit (loss) | 9901 | €71,782 | €135,119 | +€63,336 | +88.2% |
| Financial income | 75/76B | - | €372 | +€372 | |
| Recurring financial income | 75 | - | €372 | +€372 | |
| Financial charges | 65/66B | €17 | €107 | +€90 | +527% |
| Recurring financial charges | 65 | €17 | €107 | +€90 | +527% |
| Profit (loss) for the period before taxes | 9903 | €71,765 | €135,385 | +€63,619 | +88.6% |
| Income taxes | 67/77 | €18,000 | €29,088 | +€11,088 | +61.6% |
| Profit (loss) for the period | 9904 | €53,765 | €106,296 | +€52,531 | +97.7% |
| Profit (loss) for the period to be appropriated | 9905 | €53,765 | €106,296 | +€52,531 | +97.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.